CG
TEVA icon

Cutler Group’s Teva Pharmaceuticals TEVA Stock Holding History

Cutler Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,600
Closed -$4K – 5206
2022
Q3 		$4K Sell
40,600
-61,000
-60% -$539K ﹤0.01% 3857
2022
Q2 		$14K Buy
101,600
+5,100
+5% +$44.4K ﹤0.01% 2970
2022
Q1 		$71K Buy
96,500
+80,100
+488% +$668K ﹤0.01% 1969
2021
Q4 		$2K Buy
+16,400
New +$148K ﹤0.01% 4834
2020
Q1 		– Sell
-19,000
Closed -$11K – 4647
2019
Q4 		$11K Sell
19,000
-4,000
-17% -$35.7K ﹤0.01% 2604
2019
Q3 		$4K Buy
+23,000
New +$176K ﹤0.01% 3206
2019
Q2 		– Sell
-14,000
Closed -$11K – 4785
2019
Q1 		$11K Sell
14,000
-32,100
-70% -$566K ﹤0.01% 2445
2018
Q4 		$20K Hold
46,100
– – ﹤0.01% 2118
2018
Q3 		$77K Hold
46,100
– – 0.01% 1350
2018
Q2 		$124K Buy
46,100
+3,500
+8% +$71.4K 0.01% 1013
2018
Q1 		$48K Sell
42,600
-71,400
-63% -$1.39M ﹤0.01% 1693
2017
Q4 		$28K Buy
114,000
+23,300
+26% +$351K ﹤0.01% 2294
2017
Q3 		$17K Sell
90,700
-9,600
-10% -$216K ﹤0.01% 3290
2017
Q2 		$156K Buy
100,300
+54,200
+118% +$1.68M 0.01% 1476
2017
Q1 		$29K Sell
46,100
-72,400
-61% -$2.47M ﹤0.01% 2951
2016
Q4 		$13K Buy
118,500
+57,900
+96% +$2.31M ﹤0.01% 3925
2016
Q3 		$28K Sell
60,600
-16,500
-21% -$861K ﹤0.01% 3092
2016
Q2 		$142K Buy
77,100
+15,800
+26% +$841K 0.01% 1383
2016
Q1 		$258K Sell
61,300
-147,900
-71% -$8.68M 0.02% 863
2015
Q4 		$988K Buy
+209,200
New +$12.9M 0.06% 341

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Cutler Group's TEVA Position: Q1 2024 in Review

Cutler Group sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 1,900 shares — an estimated $19K sold.

Cutler Group first reported a position in TEVA in Q4 2015 and held it in 28 quarters. The position peaked at $4.65M in Q1 2017. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • Cutler Group reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 1,900 Teva Pharmaceuticals shares in Q1 2024, an estimated $19K.
  • Cutler Group first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 28 quarters.
  • Cutler Group's Teva Pharmaceuticals position peaked at $4.65M in Q1 2017.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.